| 000 | 01155 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515174230.0 | ||
| 264 | 0 | _c20090724 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(09)61104-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRossebø, Anne B | |
| 245 | 0 | 0 |
_aAortic valve stenosis. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 2009 |
||
| 300 |
_a2022-3; author reply 2023 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAortic Valve Stenosis _xetiology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHeart Valve Prosthesis Implantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHypercholesterolemia _xcomplications |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aGerdts, Eva | |
| 700 | 1 | _aPedersen, Terje R | |
| 773 | 0 |
_tLancet (London, England) _gvol. 373 _gno. 9680 _gp. 2022-3; author reply 2023 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(09)61104-1 _zAvailable from publisher's website |
| 999 |
_c18944121 _d18944121 |
||